Anlotinib plus sintilimab in patients with recurrent advanced endometrial cancer: A prospective open-label, single-arm, phase II clinical trial.Wei Wei,Xiaohua Ban,Fan Yang,Yongwen Huang,Jibin Li,Ya Qiu, Xiaqin Cheng,Jundong Li,Min ZhengANNALS OF ONCOLOGY(2021)引用 5|浏览1暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要